This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians, surgeons, specialist nurses, paediatricians, dietitians, radiologists, general practitioners and patients.
These guidelines on the management of primary sclerosing cholangitis (PSC) were commissioned by the BSG liver section.
This is a concise and up-to-date article discussing the key features of managing this condition. There are refreshers on fundamental basics such as appropriate fluid resuscitation, timing of imaging, antibiotic use and nutrition, as well as an update on the classification and management of complications. Look out for the linked podcast interviewing Dr Gavin Johnson about the article.
Chronic pancreatitis is a difficult condition to manage and the complications spill over onto several specialties, from specialist pain teams to endocrinology (brittle diabetes), rheumatology (osteoporosis) and dietetics (malnutrition). As gastroenterologists, we often have over-arching care of these patients and understanding the management of these complications as well as the closer-to-home endoscopic management (e.g. pancreatic strictures and pseudocysts), will equip us to steer their care effectively. This article covers all these topics and is an excellent update. Watch this space for a linked podcast coming soon!
Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the BSG, JAG and RCoA
No aspect of endoscopy differs more widely worldwide than the use of sedation. Why is this the case? Why do we need to re-think how we administer sedation with evolving endoscopic techniques? And how do we go about setting up an anaesthetist- delivered deep sedation service? All these important questions are addressed in this excellent paper that not only lays out the reasons why we need to re-think our practice but provides very practical guidance on how to implement change. A must read for endoscopy leads across the country.
Evidence based rational and cost-effective care for Inflammatory Bowel Disease patients managed with Biologics
The aim of this initiative was to rationalise the use of high spend biologic drug treatments in IBD...
This conference will be a timely opportunity to discuss the next steps for reducing clinical negligence in the NHS...
It is not an exaggeration to say that polypharmacy is a serious and significant public health challenge affecting populations where the number of people living into advanced years with multiple long-term conditions is increasing.
This is a new resource highlighting information that is contained in a standard pre-procedure patient endoscopy booklet.
This is the first UK national guideline to concentrate on acute lower gastrointestinal bleeding.
We would be grateful if you could complete this very short survey of your practice in relation to endoscopic balloon dilatation